Previous close | 33.40 |
Open | N/A |
Bid | 38.00 |
Ask | 42.10 |
Strike | 140.00 |
Expiry date | 2024-07-19 |
Day's range | 33.40 - 33.40 |
Contract range | N/A |
Volume | |
Open interest | 5 |
The FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat adults with familial chylomicronemia syndrome. A final decision is expected in December 2024.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.